SNHG31: A Potential Drug Target and Biomarker for Small Nucleolar RNA Host Genes

Target Name: SNHG31

NCBI ID: G101928103

SNHG31

Other Name(s): Small nucleolar RNA host gene 31 | small nucleolar RNA host gene 31

SNHG31: A Potential Drug Target and Biomarker for Small Nucleolar RNA Host Genes

Small nucleolar RNA (snRNA) host genes are a class of non-coding RNAs that play a crucial role in the regulation of gene expression during the post-transcriptional stage. These genes are involved in the production of a variety of small RNAs, which are important for various cellular processes such as DNA replication, transcript regulation, and stress response. One of the key challenges in understanding the function of snRNA host genes is the difficulty in predicting their functional outcomes, as many of these genes are not well-studied. However, the study of SNHG31, a small nucleolar RNA host gene, has shed some light on the functional implications of this gene and its potential as a drug target or biomarker.

SNHG31: Structure and Expression

SNHG31 is a 24.8-kb long gene that is located on chromosome 19 at position 686.3. It encodes a protein with 1,212 amino acids and a calculated molecular weight of 18.5 kDa. The protein is expressed in various cell types, including human embryonic stem cells, mouse primary osteoclast cells, and human keratinocytes.

Functional assays have shown that SNHG31 plays a role in regulating gene expression during the post-transcriptional stage. Specifically, the protein has been shown to interact with the protein heat shock protein (Hsp30) and the RNA polymerase II (RNA-II) complex. These interactions suggest that SNHG31 may be involved in the regulation of protein translation, an important step in gene expression.

Additionally, overexpression of SNHG31 has been shown to increase the expression of target genes, including the genes involved in cell adhesion, migration, and invasion. This increase in gene expression may contribute to the enhanced cellular phenotype of SNHG31-expressed cells.

Drug Target Potential

The drug targeting potential of SNHG31 is an attractive prospect due to its involvement in the regulation of gene expression. Several studies have identified potential drug targets for SNHG31, including the interaction with Hsp30 and RNA-II.

One potential drug target for SNHG31 is the inhibition of Hsp30, which can reduce the amount of SNHG31-bound Hsp30 and disrupt its interaction with the protein. This would result in a decrease in the amount of SNHG31-bound target genes and a decrease in the overall cellular phenotype.

Another potential drug target for SNHG31 is the inhibition of RNA-II, which can reduce the amount of SNHG31-bound RNA-II and disrupt its interaction with the protein. This would result in a decrease in the amount of SNHG31-bound target genes and a decrease in the overall cellular phenotype.

Biomarker Potential

SNHG31 has the potential to serve as a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. The increased expression of target genes and the involvement in the regulation of gene expression during the post-transcriptional stage suggest that SNHG31 may be involved in the development and progression of these diseases.

For example, the increased expression of genes involved in cell adhesion, migration, and invasion in SNHG31-expressed cells may contribute to the enhanced migration and invasion of cancer cells. This may make SNHG31 an attractive biomarker for cancer diagnosis and treatment.

Conclusion

SNHG31 is a small nucleolar RNA host gene that has been shown to play a role in the regulation of gene expression during the post-transcriptional stage. The drug targeting potential of SNHG31 is an attractive prospect due to its involvement in the regulation of gene expression and its potential involvement in the development and progression of various diseases. Further research is needed to fully understand the functional implications of SNHG31 and its potential as a drug target or biomarker.

Protein Name: Small Nucleolar RNA Host Gene 31

The "SNHG31 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNHG31 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets